2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
生物活性
Description
In Vivo
In Vitro
化合物的使用
Kinase Assay
Cell Assay
Animal Administration
参考文献
TMC207 is a first-in-class diarylquinoline compound with a novel mechanism of action, the inhibition of bacterial ATP synthase, and potent activity against drug-sensitive and drug-resistant TB. For the detailed information about the solubility of Bedaquiline (TMC207) in water, the solubility of Bedaquiline (TMC207) in DMSO, the solubility of Bedaquiline (TMC207) in PBS buffer, the animal experiment(test) of Bedaquiline (TMC207),the in vivo,in vitro and clinical trial test of Bedaquiline (TMC207),the cell experiment(test) of Bedaquiline (TMC207),the IC50, EC50 and Affinity of Bedaquiline (TMC207), please contact DC Chemicals.